Market Cap 49.66B
Revenue (ttm) 5.44B
Net Income (ttm) 4.17B
EPS (ttm) N/A
PE Ratio 33.14
Forward PE 32.91
Profit Margin 76.75%
Debt to Equity Ratio 0.06
Volume 1,642,010
Avg Vol 4,777,228
Day's Range N/A - N/A
Shares Out 580.30M
Stochastic %K 84%
Beta 1.03
Analysts Strong Sell
Price Target $93.14

Company Profile

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. I...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 250 2500
Address:
One Edwards Way, Irvine, United States
GettnFibbywIT
GettnFibbywIT Nov. 14 at 4:42 PM
$EW $XLV $IHI EW / Bulls need to see price eventually move/close above the 11/13/25 high ($87.21) and the rising upper price channel line (upward move since the July '24 sell off). Also, around that general area ($87 ish) is a 38.2% fib retracement level - From the Dec '21 highs to the July '24 price lows - as well as the upper horizontal level of the gap down window (July 24-25th 2024 gap down) as additional/converged technicals of consideration. Definitely an important price area....
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:09 AM
$EW is currently trading at $86.11, showing strong momentum with an RSI of 82.31, indicating overbought conditions. The stock is above its 30-day moving average (MA30) of 79.03 and 50-day moving average (MA50) of 78.07, suggesting a bullish trend. However, the high RSI signals potential for a pullback. Market context shows the 60-day high at $87.21, which could act as a resistance level, while the 60-day low is at $72.3, providing a significant range. Given the current price proximity to the high, a cautious approach is warranted. Suggested entry could be around $85.50 to capitalize on any potential pullback. Set a stop-loss at $83.50 to manage risk. Target 1 can be set at $87.00, just below the 60-day high, and Target 2 at $88.00 for a more aggressive exit if momentum continues. Monitor for any signs of reversal or weakening momentum before executing. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:16 AM
$EW: The current market context shows a last close of $85.25, which is near the 60D high of $87.09, indicating potential resistance. The RSI at 77.36 suggests that the stock is overbought, which may lead to a price pullback. The 30-day moving average (MA30) at $78.41 and the 50-day moving average (MA50) at $77.88 indicate bullish momentum, but the price is significantly above these averages, reinforcing the overbought condition. Directional bias is bearish in the short term due to the high RSI and proximity to the 60D high. Suggested entry for a short position could be around $85.00. Set a stop-loss at $87.50 to manage risk. Target 1 can be set at $80.00, aligning with the MA30, and Target 2 at $78.50, slightly above the MA50. Monitor for price action near the targets for potential adjustments. https://privateprofiteers.com
0 · Reply
GettnFibbywIT
GettnFibbywIT Nov. 12 at 8:55 PM
$EW $XLV $IHI Edwards Lifesciences (EW)- Got a lot of prior "stuff" going on and converging right above to be potentially aware of...Just sayin'....
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 12:52 AM
$EW: The current market context shows a last close of $85.25, which is near the 60D high of $87.09, indicating potential resistance. The RSI at 77.36 suggests that the stock is overbought, which may lead to a price pullback. The 30-day moving average (MA30) at $78.41 and the 50-day moving average (MA50) at $77.88 indicate bullish momentum, but the price is significantly above these averages, reinforcing the overbought condition. Directional bias is bearish in the short term due to the high RSI and proximity to the 60D high. Suggested entry for a short position could be around $85.00. Set a stop-loss at $87.50 to manage risk. Target 1 can be set at $80.00, aligning with the MA30, and Target 2 at $78.50, slightly above the MA50. Monitor for price action near the targets for potential adjustments. https://privateprofiteers.com
0 · Reply
hannah_wilson33
hannah_wilson33 Nov. 7 at 11:34 AM
$EW holding $90, next $92.
0 · Reply
scientificway
scientificway Nov. 6 at 10:02 PM
$EW buy low. NAGE, rev eps up, guidance up, no debt. easy to double
0 · Reply
OptionSamurai
OptionSamurai Nov. 6 at 3:55 PM
$EW appears in our scan that looks for calls that will explode if the stock goes to analyst target. Analysts rating is BUY and the target price is 14.5% away📈. Call 85.0, 16-Jan-26 has: Max loss of 3.5% compared to holding shares and Breakeven is 6.6% away. If the stock hits the target, the call will profit 226% 🔥🔥🔥. 👉 Create your own scan here: https://bit.ly/3lR1xIP
0 · Reply
JFDI
JFDI Nov. 4 at 4:13 PM
For a ticker $EW ...
0 · Reply
lee305
lee305 Nov. 3 at 6:14 PM
$ZBH $BDX $BAX $HSIC $EW yall need to get your act together and start consolidating.
0 · Reply
Latest News on EW
Edwards Lifesciences CFO Scott Ullem to step down by mid-2026

Oct 30, 2025, 4:38 PM EDT - 14 days ago

Edwards Lifesciences CFO Scott Ullem to step down by mid-2026


Edwards Lifesciences Announces CFO Transition Plan

Oct 30, 2025, 4:15 PM EDT - 15 days ago

Edwards Lifesciences Announces CFO Transition Plan


Edwards Lifesciences Reports Third Quarter Results

Oct 30, 2025, 4:13 PM EDT - 15 days ago

Edwards Lifesciences Reports Third Quarter Results


Edwards Lifesciences: Inflection Incoming, But When?

Oct 14, 2025, 2:36 PM EDT - 4 weeks ago

Edwards Lifesciences: Inflection Incoming, But When?


Edwards Lifesciences Reports Second Quarter Results

Jul 24, 2025, 4:15 PM EDT - 4 months ago

Edwards Lifesciences Reports Second Quarter Results


Edwards Lifesciences: With A Heart Beating Strong And Steady

Jun 4, 2025, 2:11 PM EDT - 5 months ago

Edwards Lifesciences: With A Heart Beating Strong And Steady


Trade Tracker: Bill Baruch buys Edwards Lifesciences

May 19, 2025, 2:13 PM EDT - 6 months ago

Trade Tracker: Bill Baruch buys Edwards Lifesciences


Edwards Lifesciences Reports First Quarter Results

Apr 23, 2025, 4:15 PM EDT - 7 months ago

Edwards Lifesciences Reports First Quarter Results


Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead

Mar 22, 2025, 11:51 PM EDT - 8 months ago

Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead


GettnFibbywIT
GettnFibbywIT Nov. 14 at 4:42 PM
$EW $XLV $IHI EW / Bulls need to see price eventually move/close above the 11/13/25 high ($87.21) and the rising upper price channel line (upward move since the July '24 sell off). Also, around that general area ($87 ish) is a 38.2% fib retracement level - From the Dec '21 highs to the July '24 price lows - as well as the upper horizontal level of the gap down window (July 24-25th 2024 gap down) as additional/converged technicals of consideration. Definitely an important price area....
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:09 AM
$EW is currently trading at $86.11, showing strong momentum with an RSI of 82.31, indicating overbought conditions. The stock is above its 30-day moving average (MA30) of 79.03 and 50-day moving average (MA50) of 78.07, suggesting a bullish trend. However, the high RSI signals potential for a pullback. Market context shows the 60-day high at $87.21, which could act as a resistance level, while the 60-day low is at $72.3, providing a significant range. Given the current price proximity to the high, a cautious approach is warranted. Suggested entry could be around $85.50 to capitalize on any potential pullback. Set a stop-loss at $83.50 to manage risk. Target 1 can be set at $87.00, just below the 60-day high, and Target 2 at $88.00 for a more aggressive exit if momentum continues. Monitor for any signs of reversal or weakening momentum before executing. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:16 AM
$EW: The current market context shows a last close of $85.25, which is near the 60D high of $87.09, indicating potential resistance. The RSI at 77.36 suggests that the stock is overbought, which may lead to a price pullback. The 30-day moving average (MA30) at $78.41 and the 50-day moving average (MA50) at $77.88 indicate bullish momentum, but the price is significantly above these averages, reinforcing the overbought condition. Directional bias is bearish in the short term due to the high RSI and proximity to the 60D high. Suggested entry for a short position could be around $85.00. Set a stop-loss at $87.50 to manage risk. Target 1 can be set at $80.00, aligning with the MA30, and Target 2 at $78.50, slightly above the MA50. Monitor for price action near the targets for potential adjustments. https://privateprofiteers.com
0 · Reply
GettnFibbywIT
GettnFibbywIT Nov. 12 at 8:55 PM
$EW $XLV $IHI Edwards Lifesciences (EW)- Got a lot of prior "stuff" going on and converging right above to be potentially aware of...Just sayin'....
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 12:52 AM
$EW: The current market context shows a last close of $85.25, which is near the 60D high of $87.09, indicating potential resistance. The RSI at 77.36 suggests that the stock is overbought, which may lead to a price pullback. The 30-day moving average (MA30) at $78.41 and the 50-day moving average (MA50) at $77.88 indicate bullish momentum, but the price is significantly above these averages, reinforcing the overbought condition. Directional bias is bearish in the short term due to the high RSI and proximity to the 60D high. Suggested entry for a short position could be around $85.00. Set a stop-loss at $87.50 to manage risk. Target 1 can be set at $80.00, aligning with the MA30, and Target 2 at $78.50, slightly above the MA50. Monitor for price action near the targets for potential adjustments. https://privateprofiteers.com
0 · Reply
hannah_wilson33
hannah_wilson33 Nov. 7 at 11:34 AM
$EW holding $90, next $92.
0 · Reply
scientificway
scientificway Nov. 6 at 10:02 PM
$EW buy low. NAGE, rev eps up, guidance up, no debt. easy to double
0 · Reply
OptionSamurai
OptionSamurai Nov. 6 at 3:55 PM
$EW appears in our scan that looks for calls that will explode if the stock goes to analyst target. Analysts rating is BUY and the target price is 14.5% away📈. Call 85.0, 16-Jan-26 has: Max loss of 3.5% compared to holding shares and Breakeven is 6.6% away. If the stock hits the target, the call will profit 226% 🔥🔥🔥. 👉 Create your own scan here: https://bit.ly/3lR1xIP
0 · Reply
JFDI
JFDI Nov. 4 at 4:13 PM
For a ticker $EW ...
0 · Reply
lee305
lee305 Nov. 3 at 6:14 PM
$ZBH $BDX $BAX $HSIC $EW yall need to get your act together and start consolidating.
0 · Reply
JarvisFlow
JarvisFlow Nov. 3 at 3:22 PM
Truist Securities has updated their rating for Edwards Lifesciences ( $EW ) to Hold with a price target of 90.
0 · Reply
IN0V8
IN0V8 Nov. 3 at 3:06 PM
$EW Buy Canaccord Genuity raises target price to $84 from $81 Raymond James raises to outperform from market perform Truist Securities raises target price to $90 from $87
0 · Reply
JarvisFlow
JarvisFlow Nov. 3 at 1:28 PM
Canaccord Genuity has adjusted their stance on Edwards Lifesciences ( $EW ), setting the rating to Hold with a target price of 81 → 84.
0 · Reply
__SquuezedChronometer_
__SquuezedChronometer_ Nov. 2 at 11:25 AM
Next major retail squeeze candidate right here $WVE $SFL $EW $STRF 2
0 · Reply
Johnnytwofour2
Johnnytwofour2 Oct. 31 at 3:04 PM
$EW What a silly day, beat across the board, riding on the data release from a few days ago, upgraded guidance. Yet the stock is under heavy selling pressure. Someone big must have shorted just above $84. Its funny, because if it breaks hard then they will be squeezed. Their is concerted effort being made to keep this off of retails radar.
0 · Reply
ZacksResearch
ZacksResearch Oct. 31 at 2:59 PM
$EW beats Q3 earnings & sales estimates — what's driving the growth? 🚀 🩺 Adjusted EPS of 67 cents, increased 8.1% from the year-ago quarter’s level, surpassed estimates by 13.6% 💰 Overall sales rose 14.8% year over year to $1.55B, driven by strong TAVR and TMTT segment performance Discover the full breakdown here 👉 https://www.zacks.com/stock/news/2782745/ew-stock-gains-on-q3-earnings-and-revenue-beat-margins-crash?cid=sm-stocktwits-2-2782745-body-18781&ADID=SYND_STOCKTWITS_TWEET_2_2782745_BODY_18781
0 · Reply
ZacksResearch
ZacksResearch Oct. 31 at 1:59 PM
$EW pops on strong Q3 beat — but margins tell another story. Earnings and revenue topped estimates thanks to robust TAVR and TMTT growth, yet profit margins took a sharp hit, raising questions about sustainability. Full breakdown of the mixed quarter here 👉 https://www.zacks.com/stock/news/2782745/ew-stock-gains-on-q3-earnings-and-revenue-beat-margins-crash?cid=sm-stocktwits-2-2782745-teaser-18779&ADID=SYND_STOCKTWITS_TWEET_2_2782745_TEASER_18779
0 · Reply
RunnerSignals
RunnerSignals Oct. 30 at 7:56 PM
Upgrade Alert 🚀 $XNCR $SWKS $AMTB $VIAV $EW all got analyst love today! XNCR leading with 85% upside potential. Triple upgrade party for SWKS. https://stocksrunner.com/news/2025-10-30-stock-upgrades-today-with-7-analyst-moves
0 · Reply
GettnFibbywIT
GettnFibbywIT Oct. 29 at 5:57 PM
0 · Reply
GettnFibbywIT
GettnFibbywIT Oct. 29 at 5:50 PM
$EW $IHI Edwards, gapping up this AM, selling off so far and near the intra-day highs...With buyers coming in below, pushing price back up and currently trading around a previously important and prior level of market memory ($83-$82 ish ) where buyers/sellers are currently battling it out for control:
0 · Reply
kcphaeton
kcphaeton Oct. 29 at 1:01 PM
$EW would like to see if Back to all-time high around $130 a year in 2021. 
0 · Reply
kcphaeton
kcphaeton Oct. 29 at 1:00 PM
$EW been a long time investor in Edwards. I’m glad to see that it’s finally moving upwards again. They definitely were a darling company until Covid. Can we get back to the all-time high of $130 per share? 
0 · Reply